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212 RHO KINASE PHOSPHORYLATES SOX9 TO ENHANCE
TRANSCRIPTIONAL ACTIVITY
D.R. Haudenschild1, J. Chen1, N. Pang1, C. Verioti2, M.K. Lotz1,
D.D. D’Lima2. 1The Scripps Research Institute, La Jolla, CA, USA,
2Shiley Center for Orthopaedic Research and Education, La Jolla, CA,
USA
Purpose: Mechanical forces inﬂuence chondrocyte gene expression and
biosynthetic response. The cellular response is dependent on the nature
and duration of applied mechanical forces, and can range from matrix
synthesis to apoptosis. Dynamic compression of moderate intensity and
duration is beneﬁcial and enhances the production of cartilage matrix
components including type II collagen and aggrecan. Mechanotrans-
duction pathways in chondrocytes that recognize applied forces and
elicit appropriate biochemical outcomes are not well characterized. A
current theory is that the actin cytoskeleton provides a framework for
the assembly of mechanosensation mechanisms. Rho GTPase activities
regulate the actin cytoskeleton, and we have shown previously that
mechanical forces activate Rho and downstream Rho Kinase (ROCK)
to cause cytoskeletal rearrangements in 3D chondrocyte cultures.
Sox9 is a transcription factor essential for cartilage formation and home-
ostasis, and it directly regulates the expression of the major collagens
and proteoglycans of the cartilage extracellular matrix including type II
collagen and aggrecan. We have identiﬁed a ROCK-dependent nuclear
translocation of Sox9 in mechanically stimulated chondrocytes. A con-
nection between ROCK signaling and Sox9 mRNA expression has also
been found by others, but Sox9 expression and transcriptional activity
are not necessarily correlated. Post-translational modiﬁcations of Sox9
may be the key to understanding its activity in cartilage. The purpose of
this manuscript is to test whether a direct interaction between ROCK and
Sox9 exists which affects Sox9 transcriptional activity.
Methods: SW1353 human chondrosarcoma cells were transiently trans-
fected with various combinations of plasmids encoding for Sox9, RhoA,
ROCK or kinase-dead ROCK, and a COL2A1 luciferase reporter. A
ROCK consensus site within Sox9 was identiﬁed by sequence analysis.
Phosphorylation was demonstrated in vitro using puriﬁed proteins, and in
cyto using overexpressed proteins. Quantiﬁcation was by immunoblotting
with a phosphoSox9-speciﬁc antibody. Transcriptional activation of Sox9
by ROCK was measured using a Sox9-luciferase reporter assay. Inhibition
of ROCK activity was with 5uM hydroxyfasudil.
Results:We identiﬁed a potential ROCK consensus site in Sox9 at serine
181.
We found that ROCK directly phosphorylates Sox9 at this site using in-
vitro puriﬁed proteins. We show that overexpression of ROCK or activation
of the RhoA pathway in SW1353 cells increases phosphorylation of Sox9
at this site. Serine 181 is contained within a nuclear localization signal,
and its phosphorylation can enhance transcription.
We further show that ROCK causes a dose-dependent increase in
transcription of a Sox9-luciferase reporter construct. In TGF-beta-treated
SW1353 cells, we show that inhibition of ROCK activity reduces the
endogenous levels of phosphorylated Sox9.
Conclusions: These results demonstrate a new interaction linking
Rho/ROCK activation to increased cartilage matrix production. The direct
phosphorylation of the transcription factor Sox9 at one of its nuclear local-
ization sites results in increased transcriptional activity. The organization
of the chondrocyte actin cytoskeleton and chondrocyte gene expression
have long appeared to be functionally linked. We believe that these results
may provide a molecular mechanism to help explain this observation.
213 EXPRESSION PROFILING OF MOUSE FEMORAL HEAD
EXPLANT CULTURES AFTER STIMULATION WITH
INTERLEUKIN-1a OR RETINOIC ACID
D. Belluoccio, R. Wilson, L. Rowley, J. Bateman. Murdoch Childrens
Research Institute, Parkville, AUSTRALIA
Purpose: Cartilage explant cultures are a valuable experimental system
for the analysis of the molecular mechanisms cartilage degradation.
Catabolic stimulation of explants with the pro-inﬂammatory cytokine
interleukin-1a (Il-1), or with retinoic acid (RetA), leads to degradation of
aggrecan and collagen II. To further explore the mechanisms of cartilage
degradation in this system, we used whole genome expression proﬁling
to characterize RetA and Il-1 induced changes in gene expression.
Methods: Femoral head cartilage of 24-day old mice were cultured in
serum-free DMEM for 2 and 4 days with either no treatment or with
addition of 10mM RetA or 10 ng/ml Il-1. Total RNA was extracted and
cRNA generated by linear ampliﬁcation (MessageAmp, Ambion), labeled
with Cy3/Cy5 and hybridized to 44k whole genome microarrays (Agilent).
Data was validated by quantitative PCR of selected genes.
Results: Toluidine blue staining of the explants indicated aggrecan loss
in RetA treated explants by 2 days compared with control cartilage, and
after 4 days when treated with Il-1. Differential gene expression of gene
groups involved in cartilage catabolism, ECM formation or development
was analyzed. We found that adamts-4 and -5 were upregulated in both
Il-1 and RetA treated cultures, while adamts-9 and -15 were preferentially
upregulated by RetA. A number of mmps, including mmp10, were upreg-
ulated by both agents, whereas others such as mmp3 were upregulated
by Il-1 and downregulated by RetA. Timp-3 was strongly downregulated
by both Il-1 and RetA, and timp-1 was upregulated by Il-1, but down-
regulated by RetA. Several members of the cathepsin family were also
differentially regulated. Cartilage ECM molecules regulated by both Il-1
and RetA, such as collagens II, IX and XI, aggrecan, ﬁbromodulin, link
protein and matrilins 1 and 3 were generally most strongly downreguled
by RetA, particularly at day-4. Other SLRPs such as decorin, biglycan
and prelp were not signiﬁcantly downregulated. In addition, differential
expression of several sox transcription factors, including sox9, and several
bmp family members was apparent.
Conclusions: The application of microarray expression proﬁling to mouse
explant cultures stimulated with Il-1 or RetA in vitro has revealed the
differential expression of many genes. Upregulation of catabolic genes
such as several adamts and mmp and cathepsins is new, but unsurprising
information, although the differential upregulation by RetA alone, in the
case of adamsts-9 and adamts-15 is a novel ﬁnding that may provide
mechanistic insights. It is important to recognize that gene expression is
only part of the equation, and the application of proteomic approaches will
be critical in dissecting the molecular pathways of cartilage degradation.
However, our data has revealed patterns of gene expression of important
candidate gene families, and of novel genes, that will be important targets
of further detailed analysis.
214 CONTROL OF CHONDROCYTE GENE EXPRESSION BY
ACTIN DYNAMICS: A NOVEL ROLE OF CHOLESTEROL/RORa
SIGNALING
A. Woods, C.G. James, F. Beier. University of Western Ontario, London,
ON, CANADA
Purpose: It is essential that we acquire a better understanding of chon-
drocyte differentiation in development as there are many parallels with
osteoarthritis, a disease partially caused by the pathological differentia-
tion of articular cartilage to hypertrophy. We have previously identiﬁed the
importance of the actin cytoskeleton and regulators of actin, the family of
Rho GTPases, in regulating chondrocyte maturation. More speciﬁcally, we
have shown that RhoA signaling inhibits multiple stages of chondrocyte
differentiation, while Rac1, Cdc42 and actin dynamics stimulate multiple
aspects of chondrocyte differentiation. In order to better assess the
effects of these signaling pathways, we analyzed global changes in
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gene expression in response to manipulating the actin cytoskeleton in
chondrocytes.
Methods: Chondrocytes isolated from embryonic mice growth plates
were plated in high density monolayer cultures and treated for 24 hours
with vehicle, 10mM Y27632 (inhibits Rho/ROCK signaling), 1mM cytocha-
lasin D (inhibits actin polymerization) or 50 nM jasplakinolide (promotes
actin polymerization). RNA was isolated, and then hybridized to Affymetrix
MOE4.0 chips. Bioinformatic analysis (MAS5.0) was performed and probe
sets demonstrating a signiﬁcant, at least 1.5-fold change and reliable
signal were considered for further analysis. These data were compared
to our previous microarray analyses of chondrocyte differentiation in vitro
and in vivo (growth plate zones of microdissected tibia, time course of mi-
cromass cultures differentiating from mesenchymal cells to hypertrophy)
we have previously analyzed.
Results: Inhibition of actin polymerization by cytochalasin D resulted in
the most compelling data in comparison to other actin manipulations.
We observed that treating growth plates with cytochalasin D resulted in
very large bones consisting entirely of cells with hypertrophic morphology.
Analysis of the gene set revealed that most genes that were upregulated
were similarly regulated in other models of chondrocyte differentiation
to hypertrophy, suggesting that cytochalasin D stimulates chondrocyte
hypertrophy, a novel ﬁnding. We continued our studies by comparing
gene sets with other models of chondrocyte hypertrophy and identiﬁed
the nuclear receptor, Rora as a common gene upregulated in all 3 models
studied. We found that Rora is most highly expressed in the hypertrophic
portion of the growth plate and is expressed throughout growth plates of
cytochalasin D treated bones. Additionally, multiple targets of Rora are
also increased in chondrocytes treated with cytochalasin D, such as fatty
acid binding protein 4, lipoprotein lipase and CD36 (a receptor previously
implicated in osteoarthritis). We also show that stimulation of Rora
by its ligand cholesterol results in a phenotype similar to chondrocyte
hypertrophy. These data suggest that cholesterol signaling through Rora
contributes to chondrocyte hypertrophy.
Interestingly, because it has been shown in other cell types that Rora
expression is regulated by Hif1a, we assessed and conﬁrmed increased
levels of Hif1a in the hypertrophic region of the growth plate and through-
out the growth plates of bones treated with cytochalasin D. Similarly, Rora
and Hif1a expression was upregulated in chondrocytes with cartilage-
speciﬁc deletion of the Rac1 gene.
Conclusions: Identiﬁcation of regulators of chondrocyte hypertrophy
will be essential in preventing pathological differentiation of articular
chondrocytes in osteoarthritis. Our data implicate the nuclear receptor
Rora and its activator cholesterol in stimulating chondrocyte hypertrophy.
These data have far reaching implications for preventing and possibly
minimalizing the severity of osteoarthritis.
215 TRANSFORMING GROWTH FACTOR ALPHA
AND ENDOTHELIN RECEPTOR A SIGNALING IN
OSTEOARTHRITIS
S.E. Usmani, C.T. Appleton, F. Beier. The University of Western Ontario,
London, ON, CANADA
Purpose: Osteoarthritis (OA) involves the degeneration of articular car-
tilage by catabolic factors. Previously, we determined that transform-
ing growth factor alpha (TGF alpha) gene expression was upregulated
in articular chondrocytes in an experimental OA model. Furthermore
we demonstrated that TGF alpha suppressed chondrocyte phenotype
and speciﬁcally induced expression of catabolic factors including matrix
metalloproteinase-13. Thus we identiﬁed TGF alpha as a candidate
causal factor in OA. Our subsequent goal was to determine downstream
targets of TGF alpha. Interestingly, microarray data from our OA model
indicate that endothelin receptor A (ETA) expression is also upregulated
in the disease state. Since ETA has already been implicated in OA and
other age-related diseases we decided to investigate whether there was
a connection between TGF alpha and ETA signaling.
The purpose of the current study was to (1) examine the upregulation
of ETA in our experimental OA model, (2) determine the effects of TGF
alpha on ETA expression, (3) evaluate whether the catabolic effects of
TGF alpha can be inhibited by blocking ETA.
Methods: RNA and histological cartilage sections from our rodent OA
model were evaluated for ETA gene and protein expression by real-
time PCR and immunohistochemistry respectively. Next primary articular
chondrocytes were isolated from newborn Sprague Dawley rats, grown
in monolayer cultures, and treated with TGF alpha (10 ng/ml) for up to
3 days. RNA was isolated from cultures and the expression of genes
implicated in OA was assessed by real-time PCR. We then isolated
articular cartilage organ culture explants and treated them with TGF
alpha for up to 7 days. Explants were sectioned and immunostained for
both ETA and inducible nitric oxide synthase (iNOS). Next we used an
endothelin receptor inhibitor in an attempt to block some of TGF alpha’s
catabolic effects. Chondrocyte cultures were treated with either vehicle,
TGF alpha, inhibitor (10mM), or a combination of both for 48 hours.
RNA was isolated and real-time PCR was performed for genes including
Mmp13, Col2a1, and Agc1.
Results: Data revealed a signiﬁcant increase in ETA gene expression
in OA animals compared to controls. There also appeared to be deeper
ETA staining in cartilage from OA animals compared to controls. In cell
cultures, Cxcr4, Tgfa and Il1b gene expression did not change after
treatment, while the expression of Ednra (ETA gene) and Tnfa increased
in response to TGF alpha. Immunohistochemistry showed that explants
treated with TGF alpha expressed more ETA than did controls. The
endothelin receptor inhibitor did not appear to block TGF alpha’s induction
of Mmp13 or inhibition of Col2a1 and Agc1 expression by TGF alpha.
Organ culture explants demonstrated an increase in iNOS expression in
TGF alpha-treated tissues compared to controls. Our current cell cultures
studies suggest that TGF alpha treatment results in increased production
of nitric oxide that can be partially blocked by inhibition of endothelin
signaling.
Conclusions: ETA expression was upregulated in our animal model of
OA as well as in TGF alpha-treated chondrocyte cultures and articular
cartilage organ cultures. Preliminary data suggest that blocking ETA may
inhibit a TGF alpha-induced increase in nitric oxide production. Thus, in
addition to TGF alpha, ETA may be another therapeutic target for OA
treatment. While blocking ETA did not appear to alter TGF alpha’s effects
on Mmp13, Col2a1 and Agc1 expression, future experiments will focus
on studying protein levels of these genes.
216 REGULATION OF MATRIX METALLOPROTEINASES
EXPRESSION BY EPAS1 IN ARTICULAR CHONDROCYTES
S. Yang, J. Kim, G. Lee, Y. Shin, J-S. Kwak, J-S. Chun. Cell Dynamics
Research Center and Department of Life Science, Gwangju institute of
Science and Technology, Gwangju, REPUBLIC OF KOREA
Purpose: Although EPAS1 plays essential roles in hypoxia and many
pathogenic conditions, the function of EPAS1 in articular chondrocytes
is unclear. In this study, we characterized a role of EPAS1 in cartilage
destruction.
Methods: EPAS1 expression and function in primary culture rabbit ar-
ticular chondrocytes were studied by RT-PCR and qRT-PCR analysis.
A role of EPAS1 in MMP expression was determined by reporter gene
assay. In vivo role of EPAS1 was examined by using collagenase- induced
osteoarthritis model using EPAS1 deﬁcient (EPAS1+/−) mouse.
Results: In primary culture articular chondrocytes, EPAS1 expression
was signiﬁcantly increased during dedifferentiation caused by interleukin-
1beta (Il-1b), epidermal growth factor, retinoic acid, or serial subculture
as monolayer. Dedifferentiation of chondrocyte accompanies induction of
several matrix metalloproteinases (MMPs) expression such as MMP-1, -3,
-9, -12, and -13, but not MMP-2, -14, and -15. Overexpression of EPAS1
by adenovires-EPAS1 induced MMP-1, -3, -9, -12, and -13 expressions,
whereas knockdown of EPAS1 by siRNA blocked Il-1b-induced expres-
sion of these MMPs. Regulatory mechanism of MMP expression was
further examined by reporter gene containing individual MMP promoter.
Reporter gene activity of MMP-1, -3, -9, -12, and -13 increased by EPAS1
transfection, and the increased activity was blocked by point mutation of
EPAS1 binding site (−CGTG−) or dominant negative EPAS1. In vivo role
of EPAS1 was examined by using EPAS1 deﬁcient (EPAS1+/−) mice, and
found that EPAS1 knockdown signiﬁcantly reduced collagenase-induced
osteoarthritis.
Conclusions: We demonstrated that EPAS1 in chondrocytes regulates
expression of MMP-1, -3, -9, -12, and -13, and EPAS1 knockdown
reduces collagenase-induced osteoarthritis in mice. Our results suggest
that EPAS1 may play a role in cartilage destruction by modulating MMP
expression.
